Top Markets
Coin of the day
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Rank in Stocks #32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lรณdz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Share Price
$0.88679187
Market Cap
$9.88M
Change (1 day)
-1.56%
Change (1 year)
-7.31%
Country
PL
Trade Pharmena S.a. (PHR)

Category

Operating Margin for Pharmena S.a. (PHR)
Operating Margin as of 2026 TTM: 0.00%
According to Pharmena S.a. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Pharmena S.a. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.